Showing: 1 - 10 of 19 RESULTS
Briefing News Psychedelics Psyence Group Pure Extracts

Pure Extracts Signs LOI For Joint Venture With Psyence Group

Pure Extracts (CSE: PULL) has entered into a letter of intent for a proposed joint venture with Psyence Group (CSE: PSYG). The proposed venture is to be focused on the extraction of psilocybin from mushrooms. The venture partner, Psyence, is one of the first commercial psilocybin cultivation and extraction facilities operating under a federally legal …

Briefing News Psychedelics Pure Extracts

Pure Extracts Submits Application For First Natural Product Number

Pure Extracts (CSE: PULL) is one step closer to commercializing its functional mushroom operation. The company this morning announced that it has received its registration with the Natural and Non-prescription Health Products Directorate. The registration enables the company to submit a Class 1 Natural Product Number for functional mushroom products, the first of which has …

Briefing Psychedelics Pure Extracts

Pure Extracts Announces Study Focused on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts (CSE: PULL) this morning announced that it has begun a study focused on that of psilocybin. More specifically, the study is focused on the formulation and manufacturing of active treatments for oral tablets, capsules and a nasal gel that are psilocybin based, which are to be used as investigational products. The study is …